October 26, 2006

Researcher To Be Sacked After Reporting High Rates of ADHD – BMJ

Researcher To Be Sacked After Reporting High Rates of ADHD – BMJ Sun, 10 Apr 2005 The

Read More
Researcher To Be Sacked After Reporting High Rates of ADHD – BMJ

October 26, 2006

Infomail Archive, 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the

Read More
Infomail Archive, 2005

October 26, 2006

Major Drug Effectiveness Review Found "Little Evidence" that ADHD drugs are safe or effective

Major Drug Effectiveness Review Found “Little Evidence” that ADHD drugs are safe or effective Tue, 13 Sep

Read More
Major Drug Effectiveness Review Found "Little Evidence" that ADHD drugs are safe or effective

October 26, 2006

FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugs

FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD

Read More
FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugs

October 26, 2006

Ritalin: Chromosome Abnormalities Occured in All 12 Children / High school prescription drug abuse

Ritalin: Chromosome Abnormalities Occured in All 12 Children / High school prescription drug abuse Fri, 11 Mar

Read More
Ritalin: Chromosome Abnormalities Occured in All 12 Children / High school prescription drug abuse

October 26, 2006

A Lobbying Campaign for Screening Children for Mental Problems

A Lobbying Campaign for Screening Children for Mental Problems–a Gimmick Aimed at Increasing PhRMA Profits Wed, 11

Read More
A Lobbying Campaign for Screening Children for Mental Problems

October 26, 2006

Labeling Kids Mentally Ill for Profit – E. Pringle

Labeling Kids Mentally Ill for Profit – E. Pringle Mon, 14 Mar 2005 Independent, investigative reporters in

Read More
Labeling Kids Mentally Ill for Profit – E. Pringle

October 26, 2006

AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall

AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall Wed, 29

Read More
AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall

October 26, 2006

AHRP Testimony: Protections for Foster Children Enrolled in Clinical Trials Submitted to Cong.Ways & Means Hearing

 THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) https://ahrp.org 142 West End Ave. Suite 28P New York, NY

Read More
AHRP Testimony: Protections for Foster Children Enrolled in Clinical Trials Submitted to Cong.Ways & Means Hearing

October 26, 2006

ADHD drug Cylert withdrawn from market due to Liver Toxicity

ADHD drug – Cylert withdrawn from market due to Liver Toxicity, a Major Risk of Psychotropic Drugs

Read More
ADHD drug Cylert withdrawn from market due to Liver Toxicity

October 26, 2006

FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street

FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street Sun,

Read More
FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street

October 26, 2006

Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP

Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP Sun, 23

Read More
Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP

October 19, 2006

NIMH pushes psych drugs for preschool tots

One day after a CBS News investigative report exposed the abusive drugging of children in foster care, a news 

Read More
NIMH pushes psych drugs for preschool tots

October 9, 2006

FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing

On Friday, October 6, FDA approved expanded use of Johnson & Johnson’s drug, Risperdal (risperidone) approved for

Read More
FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing